Onesource Specialty Pharma Ltd Quarterly Result
OneSource Specialty Pharma Ltd
NSE: ONESOURCE
Net Profit - Last Quarter
OneSource Specialty Pharma Ltd Quarterly Results Key Highlights
- The revenue of OneSource Specialty Pharma Ltd for the Mar '26 is ₹ 430.34 crore as compare to the Dec '25 revenue of ₹ 294.97 crore.
- This represent the growth of 45.89% The ebitda of OneSource Specialty Pharma Ltd for the Mar '26 is ₹ 94.05 crore as compare to the Dec '25 ebitda of ₹ 14.86 crore.
- This represent the growth of 532.91% The net profit of OneSource Specialty Pharma Ltd for the Mar '26 is ₹ 4.6 crore as compare to the Dec '25 net profit of ₹ -88.7 crore.
- This represent the decline of -105%.
OneSource Specialty Pharma Ltd Quarterly Results Analysis
Market Price of OneSource Specialty Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 29 May 2026 | 1814.55 |
| 27 May 2026 | 1792.85 |
| 26 May 2026 | 1801.6 |
| 25 May 2026 | 1809.3 |
| 22 May 2026 | 1834.15 |
| 21 May 2026 | 1861.95 |
| 20 May 2026 | 1867.6 |
| 19 May 2026 | 1853.6 |
| 18 May 2026 | 1808.8 |
| 15 May 2026 | 1834.35 |
Historical Revenue of OneSource Specialty Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of OneSource Specialty Pharma Ltd
Historical EBITDA of OneSource Specialty Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of OneSource Specialty Pharma Ltd
Historical Net Profit of OneSource Specialty Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of OneSource Specialty Pharma Ltd
OneSource Specialty Pharma Ltd News Hub
OneSource Specialty Pharma allots 3,150 equity shares under ESOP
OneSource Specialty Pharma has allotted 3,150 equity shares under ESOP on 13 May 2026. With this all
Read more
13 May 26
OneSource Specialty Pharma to convene board meeting
OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 Januar
Read more
25 Jan 25
Shares of Onesource Specialty Pharma list in T Group
The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January
Read more
24 Jan 25
OneSource Specialty Pharma reports consolidated net loss of Rs 68.85 crore in the December 2024 quarter
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024
Read more
29 Jan 25
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About OneSource Specialty Pharma Ltd
- Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
- The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
- The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
- Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.
FAQs for Quarterly Results of OneSource Specialty Pharma Ltd
What key financial metrics are included in OneSource Specialty Pharma Ltd's quarterly results?
When does OneSource Specialty Pharma Ltd announce its quarterly results?
How does OneSource Specialty Pharma Ltd's quarterly performance impact its stock price?
What is the impact of OneSource Specialty Pharma Ltd's quarterly results on dividends?
Are there any special announcements usually made during OneSource Specialty Pharma Ltd's quarterly results?
